上海
分享至
6月28日上午，港股和铂医药涨近6%，和铂医药公告称，B7H4X4-1BB双特异性抗体获美国FDA新药研究许可。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
